Adenosine 5′‐monophosphate‐activated protein kinase (AMPK) activation induces modulated adipose tissue metabolism, facilitating lipid turnover and reducing overall body fat, thus addressing the obesity component of the condition (Hardie 2011). The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.